Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared wi... और पढ़ें
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherap... और पढ़ें
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748702) titled 'Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy Volunteers'... और पढ़ें
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750769) titled 'Opioid-Free Analgesia for Laparoscopic Cholecystectomy' on Aug. 02. Brief Summary: laparosc... और पढ़ें
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Stu... और पढ़ें
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating t... और पढ़ें
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Plac... और पढ़ें
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... और पढ़ें
U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750210) titled 'Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Typ... और पढ़ें
Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... और पढ़ें